Article Information
History
- April 10, 2021.
Article Versions
- You are currently viewing Version 1 of this article (April 10, 2021 - 22:48).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- A Casadevall1,*,
- Q Dragotakes1,
- PW Johnson2,
- JW Senefeld3,
- SA Klassen3,
- RS Wright3,
- MJ Joyner3,#,
- N Paneth4,# and
- R Carter2,#
- 1Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, MD
- 2Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL
- 3Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN
- 4Department of Epidemiology and Biostatistics and Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI
- ↵*Address Correspondence: Arturo Casadevall, 615 N. Wolfe Street, Room E5132, Baltimore, Maryland 21205, acasade1{at}jhu.edu
Posted April 10, 2021.
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Convalescent Plasma Hesitancy cost lives?
